Our investigation extends this paradigm by revealing a novel vulnerability in ChaC1-overexpressed HCC systems, where ultralow AUR concentrations (~0.5 μM) elicit non-canonical cell death refractory to pan-caspase inhibitors (apoptosis), necroptosis blockers, or ferroptosis suppressors. The gene discussed is CHAC1; the disease is hepatocellular carcinoma.